DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,561,774 | +3.4% | 38,540 | 0.0% | 0.12% | +16.5% |
| Q2 2023 | $9,249,600 | -4.5% | 38,540 | +0.2% | 0.10% | -16.9% |
| Q1 2023 | $9,690,182 | -5.1% | 38,447 | -0.1% | 0.12% | -15.1% |
| Q4 2022 | $10,214,688 | +5.0% | 38,485 | +2.2% | 0.15% | +2.8% |
| Q3 2022 | $9,729,000 | +1.9% | 37,668 | 0.0% | 0.14% | +13.6% |
| Q2 2022 | $9,549,000 | -11.0% | 37,668 | +3.0% | 0.12% | +22.5% |
| Q1 2022 | $10,730,000 | -12.6% | 36,582 | -2.0% | 0.10% | +1.0% |
| Q4 2021 | $12,276,000 | +4.1% | 37,312 | -3.7% | 0.10% | +236.7% |
| Q3 2021 | $11,798,000 | +13.4% | 38,754 | -0.0% | 0.03% | -66.7% |
| Q2 2021 | $10,403,000 | -7.5% | 38,764 | -22.4% | 0.09% | -16.7% |
| Q1 2021 | $11,242,000 | -10.8% | 49,949 | -11.9% | 0.11% | -1.8% |
| Q4 2020 | $12,599,000 | -31.5% | 56,718 | -33.6% | 0.11% | -45.3% |
| Q3 2020 | $18,397,000 | +21.0% | 85,435 | -0.7% | 0.20% | +13.6% |
| Q2 2020 | $15,207,000 | +38.8% | 86,000 | +8.6% | 0.18% | +16.4% |
| Q1 2020 | $10,960,000 | +15.9% | 79,182 | +28.5% | 0.15% | +44.8% |
| Q4 2019 | $9,456,000 | +17.0% | 61,607 | +10.1% | 0.10% | +14.1% |
| Q3 2019 | $8,084,000 | +5.7% | 55,966 | +4.6% | 0.09% | +13.6% |
| Q2 2019 | $7,645,000 | +10.0% | 53,490 | +1.6% | 0.08% | +20.9% |
| Q1 2019 | $6,949,000 | +46.0% | 52,629 | +14.0% | 0.07% | +36.7% |
| Q4 2018 | $4,761,000 | -2.8% | 46,163 | +2.4% | 0.05% | +22.5% |
| Q3 2018 | $4,899,000 | +13.2% | 45,087 | +2.8% | 0.04% | +14.3% |
| Q2 2018 | $4,329,000 | -23.8% | 43,879 | -24.4% | 0.04% | -23.9% |
| Q1 2018 | $5,680,000 | +7.4% | 58,010 | +1.8% | 0.05% | +7.0% |
| Q4 2017 | $5,291,000 | +3.9% | 56,998 | -4.0% | 0.04% | +7.5% |
| Q3 2017 | $5,093,000 | +3.5% | 59,367 | +1.8% | 0.04% | -2.4% |
| Q2 2017 | $4,923,000 | +26.0% | 58,335 | +27.7% | 0.04% | +24.2% |
| Q1 2017 | $3,907,000 | -37.9% | 45,675 | -43.5% | 0.03% | -29.8% |
| Q4 2016 | $6,292,000 | +11.9% | 80,827 | +12.7% | 0.05% | +9.3% |
| Q3 2016 | $5,623,000 | -21.0% | 71,730 | +1.7% | 0.04% | -20.4% |
| Q2 2016 | $7,121,000 | +4.6% | 70,505 | -1.7% | 0.05% | +8.0% |
| Q1 2016 | $6,805,000 | +56.7% | 71,744 | +53.4% | 0.05% | +61.3% |
| Q4 2015 | $4,344,000 | +11.3% | 46,766 | +2.1% | 0.03% | +10.7% |
| Q3 2015 | $3,902,000 | -2.5% | 45,796 | -2.1% | 0.03% | +7.7% |
| Q2 2015 | $4,003,000 | -73.6% | 46,769 | -73.8% | 0.03% | -64.4% |
| Q1 2015 | $15,165,000 | +3.3% | 178,619 | +4.3% | 0.07% | +19.7% |
| Q4 2014 | $14,684,000 | -39.6% | 171,319 | -46.5% | 0.06% | -37.8% |
| Q3 2014 | $24,330,000 | -4.4% | 320,216 | -1.0% | 0.10% | -6.7% |
| Q2 2014 | $25,457,000 | +6.0% | 323,341 | +1.0% | 0.10% | +5.0% |
| Q1 2014 | $24,007,000 | -2.9% | 320,096 | -0.0% | 0.10% | -3.8% |
| Q4 2013 | $24,724,000 | +11.5% | 320,248 | +0.1% | 0.10% | +2.0% |
| Q3 2013 | $22,167,000 | -43.8% | 319,778 | -48.6% | 0.10% | +5.2% |
| Q2 2013 | $39,410,000 | – | 622,566 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |